Men living with HIV (MLHIV) have a high burden of human papillomavirus (HPV)-related cancer. Understanding serological dynamics of HPV in men can guide decisions on introducing HPV vaccination and monitoring impact.
With the rapid spread of COVID-19 across Africa, m2m President & CEO, Frank Beadle de Palomo, looks at how countries and organisations are harnessing lessons learned from the HIV/AIDS response to mitigate the impact of this new pandemic.
The HIV pandemic provides lessons for the response to the novel coronavirus disease 2019 (COVID-19) pandemic: no vaccine is available for either and there are no licensed pharmaceuticals for COVID-19, just as there was not for HIV infection in the early years.
South Africa has spent the last two decades fighting against its deadly HIV and TB epidemics, and many of its HIV researchers are now mustering their expertise to battle the Covid-19 pandemic.The scientific community has “galvanized” to investigate the novel coronavirus and the disease it causes,
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is deeply committed to continuing global progress toward controlling the HIV epidemic. As we join the world in confronting the unique challenges posed by the novel coronavirus (COVID-19), we are dedicated to doing what is needed to serve, support, and protect our clients, communities, staff, and partners around the world.
In 2017, tuberculosis caused an estimated 1·6 million deaths, including 300 000 deaths among people with HIV, and surpassed HIV/AIDS to become the leading infectious cause of mortality worldwide. Approximately 36% of tuberculosis cases each year (around 3·5 million cases) are not diagnosed or rep
The diagnostic accuracy of Xpert MTB/RIF is well documented, anticipated improvements in patient outcomes have not been clearly identified. We performed an individual patient data meta-analysis to examine improvements in patient outcomes associated with Xpert MTB/RIF.